These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
743 related articles for article (PubMed ID: 14522910)
1. Promotion of angiogenesis by ps20 in the differential reactive stroma prostate cancer xenograft model. McAlhany SJ; Ressler SJ; Larsen M; Tuxhorn JA; Yang F; Dang TD; Rowley DR Cancer Res; 2003 Sep; 63(18):5859-65. PubMed ID: 14522910 [TBL] [Abstract][Full Text] [Related]
2. Stromal cells promote angiogenesis and growth of human prostate tumors in a differential reactive stroma (DRS) xenograft model. Tuxhorn JA; McAlhany SJ; Dang TD; Ayala GE; Rowley DR Cancer Res; 2002 Jun; 62(11):3298-307. PubMed ID: 12036948 [TBL] [Abstract][Full Text] [Related]
3. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Yang F; Strand DW; Rowley DR Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of transforming growth factor-beta activity decreases angiogenesis in a human prostate cancer-reactive stroma xenograft model. Tuxhorn JA; McAlhany SJ; Yang F; Dang TD; Rowley DR Cancer Res; 2002 Nov; 62(21):6021-5. PubMed ID: 12414622 [TBL] [Abstract][Full Text] [Related]
5. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Tuxhorn JA; Ayala GE; Smith MJ; Smith VC; Dang TD; Rowley DR Clin Cancer Res; 2002 Sep; 8(9):2912-23. PubMed ID: 12231536 [TBL] [Abstract][Full Text] [Related]
6. Blockade of transforming growth factor-beta signaling suppresses progression of androgen-independent human prostate cancer in nude mice. Zhang F; Lee J; Lu S; Pettaway CA; Dong Z Clin Cancer Res; 2005 Jun; 11(12):4512-20. PubMed ID: 15958637 [TBL] [Abstract][Full Text] [Related]
7. Decreased stromal expression and increased epithelial expression of WFDC1/ps20 in prostate cancer is associated with reduced recurrence-free survival. McAlhany SJ; Ayala GE; Frolov A; Ressler SJ; Wheeler TM; Watson JE; Collins C; Rowley DR Prostate; 2004 Oct; 61(2):182-91. PubMed ID: 15305341 [TBL] [Abstract][Full Text] [Related]
8. Stromal expression of connective tissue growth factor promotes angiogenesis and prostate cancer tumorigenesis. Yang F; Tuxhorn JA; Ressler SJ; McAlhany SJ; Dang TD; Rowley DR Cancer Res; 2005 Oct; 65(19):8887-95. PubMed ID: 16204060 [TBL] [Abstract][Full Text] [Related]
9. Anti-vascular endothelial growth factor receptor 2 antibody reduces tumorigenicity and metastasis in orthotopic prostate cancer xenografts via induction of endothelial cell apoptosis and reduction of endothelial cell matrix metalloproteinase type 9 production. Sweeney P; Karashima T; Kim SJ; Kedar D; Mian B; Huang S; Baker C; Fan Z; Hicklin DJ; Pettaway CA; Dinney CP Clin Cancer Res; 2002 Aug; 8(8):2714-24. PubMed ID: 12171905 [TBL] [Abstract][Full Text] [Related]
10. Cotargeting tumor and stroma in a novel chimeric tumor model involving the growth of both human prostate cancer and bone stromal cells. Hsieh CL; Gardner TA; Miao L; Balian G; Chung LW Cancer Gene Ther; 2004 Feb; 11(2):148-55. PubMed ID: 14695756 [TBL] [Abstract][Full Text] [Related]
12. Molecular analysis of WFDC1/ps20 gene in prostate cancer. Watson JE; Kamkar S; James K; Kowbel D; Andaya A; Paris PL; Simko J; Carroll P; McAlhany S; Rowley D; Collins C Prostate; 2004 Oct; 61(2):192-9. PubMed ID: 15305342 [TBL] [Abstract][Full Text] [Related]
13. Tumor-host interaction mediates the regression of BK virus-induced vascular tumors in mice: involvement of transforming growth factor-beta1. Corallini A; Possati L; Trabanelli C; Giraudo E; Rocchetti R; Talevi S; Caputo A; Bussolino F; Barbanti-Brodano G Carcinogenesis; 2003 Sep; 24(9):1435-44. PubMed ID: 12844479 [TBL] [Abstract][Full Text] [Related]
14. Smad3 is overexpressed in advanced human prostate cancer and necessary for progressive growth of prostate cancer cells in nude mice. Lu S; Lee J; Revelo M; Wang X; Lu S; Dong Z Clin Cancer Res; 2007 Oct; 13(19):5692-702. PubMed ID: 17908958 [TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta1 modulates tumor-stromal cell interactions of prostate cancer through insulin-like growth factor-I. Kawada M; Inoue H; Arakawa M; Ikeda D Anticancer Res; 2008; 28(2A):721-30. PubMed ID: 18507013 [TBL] [Abstract][Full Text] [Related]
16. Role of interleukin 10 and transforming growth factor beta1 in the angiogenesis and metastasis of human prostate primary tumor lines from orthotopic implants in severe combined immunodeficiency mice. Stearns ME; Garcia FU; Fudge K; Rhim J; Wang M Clin Cancer Res; 1999 Mar; 5(3):711-20. PubMed ID: 10100726 [TBL] [Abstract][Full Text] [Related]
17. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling. Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464 [TBL] [Abstract][Full Text] [Related]
19. Cross-talk between paracrine-acting cytokine and chemokine pathways promotes malignancy in benign human prostatic epithelium. Ao M; Franco OE; Park D; Raman D; Williams K; Hayward SW Cancer Res; 2007 May; 67(9):4244-53. PubMed ID: 17483336 [TBL] [Abstract][Full Text] [Related]
20. Adenovirus-mediated interferon-beta gene transfer inhibits angiogenesis in and progression of orthotopic tumors of human prostate cancer cells in nude mice. Lee J; Wang A; Hu Q; Lu S; Dong Z Int J Oncol; 2006 Dec; 29(6):1405-12. PubMed ID: 17088978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]